Nelson Brittany L, Warren Shayla M, Xeroegeanes Thea, Zuleger Taylor M, Premkumar Ajay, Myer Gregory D, Kashikar-Zuck Susmita, Diekfuss Jed A
Emory Sports Performance And Research Center (SPARC) Flowery Branch Georgia USA.
Emory Sports Medicine Center Atlanta Georgia USA.
J Exp Orthop. 2025 Jul 13;12(3):e70352. doi: 10.1002/jeo2.70352. eCollection 2025 Jul.
Opioids prescribed to reduce pain and aid in recovery following anterior cruciate ligament reconstruction (ACLR) may pose a risk of future substance use disorder. The purpose of this study was to determine if pre-operative anxiety and depression differentiated opioid intake following ACLR. The contribution of sex, age, and graft type to post-operative opioid usage was also explored.
Data from 237 participants ( = 30.75 ± 13.29 years; 57% females; 76% all-soft tissue quadriceps tendon autograft) were analysed. Four-item Anxiety and Depression Patient Reported Outcomes Measurement Information System (PROMIS) scales were administered on the day of surgery, and opioid intake was assessed post-operatively. Patients were classified into 'anxious' or 'depressed' groups based on their PROMIS scores.
Patients took an average of one opioid pill daily. Females with pre-operative anxiety reported significantly greater post-operative opioid intake ( = 4.40 ± 3.98) than females with no anxiety ( = 2.90 ± 3.97) ( = 2199, = 0.03; = 0.36). No other significant effects were found ( > 0.05).
Anxiety, but not depression, was a risk factor for elevated opioid use in females undergoing ACLR. Interestingly, opioid intake between males and females, as well as by age and graft type, were comparable overall, indicating the unique influence of psychological rather than biological or demographic factors on opioid use following ACLR. Clinicians should consider biopsychosocial assessments to support preoperative opioid counselling, particularly in females with anxiety undergoing ACLR.
Level IV.
用于减轻前交叉韧带重建术(ACLR)后疼痛并辅助恢复的阿片类药物可能会带来未来物质使用障碍的风险。本研究的目的是确定术前焦虑和抑郁是否会使ACLR后的阿片类药物摄入量产生差异。还探讨了性别、年龄和移植物类型对术后阿片类药物使用的影响。
分析了237名参与者的数据(年龄=30.75±13.29岁;57%为女性;76%采用全软组织股四头肌肌腱自体移植)。在手术当天使用四项焦虑和抑郁患者报告结局测量信息系统(PROMIS)量表,并在术后评估阿片类药物摄入量。根据患者的PROMIS评分将其分为“焦虑”或“抑郁”组。
患者平均每天服用一粒阿片类药物。术前焦虑的女性术后阿片类药物摄入量(=4.40±3.98)显著高于无焦虑的女性(=2.90±3.97)(=2199,=0.03;=0.36)。未发现其他显著影响(>0.05)。
焦虑而非抑郁是接受ACLR的女性阿片类药物使用量增加的危险因素。有趣的是,男性和女性之间以及按年龄和移植物类型划分的阿片类药物摄入量总体相当,这表明心理因素而非生物学或人口统计学因素对ACLR后阿片类药物使用有独特影响。临床医生应考虑进行生物心理社会评估,以支持术前阿片类药物咨询,特别是对于接受ACLR且有焦虑的女性。
四级。